Mhra in a sentence

But MHRA guidance states: “Do not smoke, use naked flames or get near to anything which may cause a fire whilst wearing clothing or a bandage that has been in contact with skin creams.

But, "there have been some suspected reports of new-onset or aggravation of pre-existing myasthenia gravis or ocular myasthenia associated with statin use", the MHRA said.

But this is a self-certification and the MHRA does not carry out any tests on the product during this registration.

Dr Harris added: 'We know the Government is aware of these challenges, demonstrated by giving the MHRA an additional £10million to help bring new medicines and technologies to UK patients more quickly in the last budget.

The MHRA told medics to refer patients suffering new-onset myasthenia gravis after starting statins to a neurology specialist.

The risk in people who have used pholcodine is extremely small and the MHRA has taken this decision as a precaution.

Those that comply with these standards are given a Traditional Herbal Registration (THR) by the MHRA, which must be displayed on the packaging.

Under the MHRA's own rules, it should finish assessing all applications within a 30 days, or within 10 days after its has received any final information.

Dr Alison Cave, chief safety officer at the MHRA, said: “Returning to school after the summer holidays is a busy time for children, parents and schools alike.

Find out more about the MHRA on GOV.

The MHRA (Medicines and Healthcare products Regulatory Agency) estimates that adverse reactions occur in between one and 10 people in every 10,000 who take fluoroquinolones.

The MHRA says it continuously monitors the safety of all medicines.

Dr June Raine, chief executive of British regulator the MHRA, said the recommendation followed “an extremely thorough and scientifically rigorous review of all the evidence of safety of effectiveness and if quality” of the vaccine.

Dr Kirsty Wydenbach, from the MHRA, said the work was of “huge value”, adding: “We support CID trials and acknowledgement of the challenges of planning and conducting such trials is key.

Graeme Tunbridge, director of devices at the MHRA, said: “Patient safety and public health are our main priorities — and it is in the interests of everyone for antibody tests to be as reliable and meaningful as they can be.

He added: “I genuinely have said to my 78-year-old mum, who’s probably listening now – ‘Mum, you must have this vaccine, or any of the vaccines that the MHRA approves as soon as they are available.

Production is scheduled to begin this week, with approval from the government’s Medical and Healthcare products Regulatory Agency (MHRA) likely to prove straightforward.

The British regulatory agency, the Medicines and Healthcare Products Regulatory Authority, or MHRA, announced early Wednesday the approval of the vaccine from Pfizer and the German company BioNTech for emergency use.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved the jab after “months of rigorous clinical trials and a thorough analysis of the data by experts”, said a spokesperson for the Department of Health and Social Care on Wednesday.

The Medicines and Healthcare Regulatory Agency (MHRA) is thought to be ready to authorise the vaccines on December 28 or 29 after final data is provided to the regulator on Monday.